Cover
Cover | Jun. 06, 2022 |
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Jun. 6, 2022 |
Entity File Number | 001-39685 |
Entity Registrant Name | INMED PHARMACEUTICALS INC. |
Entity Central Index Key | 0001728328 |
Entity Tax Identification Number | 98-1428279 |
Entity Incorporation, State or Country Code | A1 |
Entity Address, Address Line One | InMed Pharmaceuticals Inc. |
Entity Address, Address Line Two | Suite 310 - 815 W. Hastings Street |
Entity Address, City or Town | Vancouver, B.C |
Entity Address, Country | CA |
Entity Address, Postal Zip Code | V6C 1B4 |
City Area Code | 604 |
Local Phone Number | 669-7207 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Shares, no par value |
Trading Symbol | INM |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Elected Not To Use the Extended Transition Period | false |